Navigating the path from therapeutics development to commercialization is filled with challenges, marked by peaks and troughs rather than a seamless journey. In the realm of Life Sciences, Mergers and Acquisitions (M&A) are frequent occurrences along this path, often resulting in the potential loss of your Employee Value Proposition (EVP). Explore how Recruitment Process Outsourcing (RPO) can serve as a valuable asset in this journey, preserving morale and culture amidst the turbulence of an acquisition process: https://lnkd.in/eiwj6GcF #SkillsAlliance #MandA #TalentAcquisition #WorkforcePlanning
Skills Alliance’s Post
More Relevant Posts
-
Navigating the path from therapeutics development to commercialization is filled with challenges, marked by peaks and troughs rather than a seamless journey. In the realm of Life Sciences, Mergers and Acquisitions (M&A) are frequent occurrences along this path, often resulting in the potential loss of your Employee Value Proposition (EVP). Explore how Recruitment Process Outsourcing (RPO) can serve as a valuable asset in this journey, preserving morale and culture amidst the turbulence of an acquisition process: https://lnkd.in/evYf-uQf #SkillsAlliance #MandA #TalentAcquisition #WorkforcePlanning
-
-
Propelling therapeutics to commercialisation comes with its peaks and troughs and is anything but a smooth journey. Mergers and Acquisitions (M&A) in Life Sciences are common throughout the process and often resolve in losing your Employee Value Proposition (EVP). Discover how a Recruitment Process Outsourcing (RPO) can aid this journey and ensure your morale and culture remain throughout an acquisition process. Find out more: https://lnkd.in/gxgFQGFj #LifeSciences #Recruitment #RPO #TalentAquisition
-
-
Propelling therapeutics to commercialisation comes with its peaks and troughs and is anything but a smooth journey. Mergers and Acquisitions (M&A) in Life Sciences are common throughout the process but can often result in losing your Employee Value Proposition (EVP). Discover how a Recruitment Process Outsourcing (RPO) can aid this journey and ensure your morale and culture remain throughout an acquisition process. Find out more: https://lnkd.in/egXkkUUK #LifeSciences #Recruitment #RPO #TalentAquisition
-
-
Propelling therapeutics to commercialisation comes with its peaks and troughs and is anything but a smooth journey. Mergers and Acquisitions (M&A) in Life Sciences are common throughout the process and often resolve in losing your Employee Value Proposition (EVP). Discover how a Recruitment Process Outsourcing (RPO) can aid this journey and ensure your morale and culture remain throughout an acquisition process. Find out more: https://lnkd.in/e6bZnbeE #LifeSciences #Recruitment #RPO #TalentAquisition
-
-
How will the Inflation Reduction Act (IRA) impact M&A considerations and clinical development in 2024? Experts at Goldman Sachs and Parexel sat down to discuss the potential implications of increased regulatory involvement and the loss of patient exclusivity on the mergers and acquisitions environment. See the full video and other highlights from our panel discussion “Decoding Healthcare’s Future” here: https://lnkd.in/dCzjT_wD #ParexelBiotech #Regulatory #IRA #ClinicalResearch
-
How will the Inflation Reduction Act (IRA) impact M&A considerations and clinical development in 2024? Experts at Goldman Sachs and Parexel sat down to discuss the potential implications of increased regulatory involvement and the loss of patient exclusivity on the mergers and acquisitions environment. See the full video and other highlights from our panel discussion “Decoding Healthcare’s Future” here: https://lnkd.in/dcNJzHAq #ParexelBiotech #Regulatory #IRA #ClinicalResearch
-
How will the Inflation Reduction Act (IRA) impact M&A considerations and clinical development in 2024? Experts at Goldman Sachs and Parexel sat down to discuss the potential implications of increased regulatory involvement and the loss of patient exclusivity on the mergers and acquisitions environment. See the full video and other highlights from our panel discussion “Decoding Healthcare’s Future” here: https://lnkd.in/gYvVeiN4 #ParexelBiotech #Regulatory #IRA #ClinicalResearch
-
How will the Inflation Reduction Act (IRA) impact M&A considerations and clinical development in 2024? Experts at Goldman Sachs and Parexel sat down to discuss the potential implications of increased regulatory involvement and the loss of patient exclusivity on the mergers and acquisitions environment. See the full video and other highlights from our panel discussion “Decoding Healthcare’s Future” here: https://lnkd.in/dcNJzHAq #ParexelBiotech #Regulatory #IRA #ClinicalResearch
-
Vice President-Creative Services, Patient Communications, Global Meetings, Editorial and Digital Engagement at Parexel International
How will the Inflation Reduction Act (IRA) impact M&A considerations and clinical development in 2024? Experts at Goldman Sachs and Parexel sat down to discuss the potential implications of increased regulatory involvement and the loss of patient exclusivity on the mergers and acquisitions environment. See the full video and other highlights from our panel discussion “Decoding Healthcare’s Future” here: https://lnkd.in/g2bB75Ys #ParexelBiotech #Regulatory #IRA #ClinicalResearch
-
How will the Inflation Reduction Act (IRA) impact M&A considerations and clinical development in 2024? Experts at Goldman Sachs and Parexel sat down to discuss the potential implications of increased regulatory involvement and the loss of patient exclusivity on the mergers and acquisitions environment. See the full video and other highlights from our panel discussion “Decoding Healthcare’s Future” here: https://lnkd.in/dPVi676u #ParexelBiotech #Regulatory #IRA #ClinicalResearch
